Martin gained his PhD at Edinburgh Napier University in 2009, in Nanoparticle In Vitro Toxicology, and spent the next 7.5 years in Switzerland conducting his post-doctoral research career before joining Swansea University Medical School in Dec 2015. Since post-graduate study, Martin has remained in the discipline of Nanotoxicology. He is motivated and enthusiastic, with core competence in nanotoxicology (particle and fibre toxicology). Martin’s research is focused on the nanoparticle-(mammalian)cell interaction, with a view to determining the mechanistic toxicological, immunological and genotoxic effects that nanoparticles, with varying physico-chemcial characteristics, may cause at the cellular level by using advanced, next-level in vitro systems combined with state-of-the-art microscopy and bioanalytical approaches. Special interests include the ability for nanoparticle shape (e.g. spheres, stars, fibres, whiskers) and surface properties (e.g. charge, protein interactions, peptides) to interfere with the human immune system and bloodstream. Another clear ambition of Martin's research is to create, study and promote alternative in vitro models that mimic in vivo environments to gain a mechanistic understanding of how nano-sized materials may, potentially, be adverse to human health. Special focus is also given to creating disease-based in vitro models and the role nanoparticles play in disease progression/exacerbation. He has a keen interest in biotechnology and bionanomaterials, with an eye to manipulate the many novel nanomaterial properties to create sophisticated bionano applications. Martin is Associate Editor for the Journal of Nanobiotechnology and Editorial board member for both Particle and Fibre Toxicology, and Food and Chemical Toxicology. Martin is a Fellow of the European Respiratory Society, Member of the Royal Society of Biology and the UK Environmental Mutagenesis Society and Committee Member of the UK In Vitro Toxicology Society.